Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor
By Zhen-lin Yang, Shuo Han, M. Keller, A. Kaiser, Brian Joseph Bender, Mathias Bosse, Kerstin Burkert, L. M. Kögler, David Wifling, G. Bernhardt and 16 more. 2018
127 citations recorded by the source corpus.
Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor superfamily and have important roles in food intake, anxiety and cancer biology1,2. The NPY–Y receptor system has emerged as one of the most complex networks with three peptide ligands (NPY, peptide YY and pancreatic polypeptide) binding to four receptors in most mammals, namely the Y1, Y2, Y4 and Y5 receptors, with different affinity and selectivity3. NPY is the most powerful stimulant of food intake and this effect is primarily mediated by the Y1 receptor (Y1R)4. A number of peptides and small-molecule compounds have been characterized as Y1R antagonists and have shown clinical potential in the treatment of obesity4, tumour1 and bone loss5. However, their clinical usage has been hampered by low potency and selectivity, poor brain penetration ability or lack of oral bioavailability6. Here we report crystal structures of the human Y1R bound to the two selective antagonists UR-MK299 and BMS-193885 at 2.7 and 3.0 Å resolution, respectively. The structures combined with mutagenesis studies reveal the binding modes of Y1R to several structurally diverse antagonists and the determinants of ligand selectivity. The Y1R structure and molecular docking of the endogenous agonist NPY, together with nuclear magnetic resonance, photo-crosslinking and functional studies, provide insights into the binding behaviour of the agonist and for the first time, to our knowledge, determine the interaction of its N terminus with the receptor. These insights into Y1R can enable structure-based drug discovery that targets NPY receptors. Crystal structures of the neuropeptide Y1 receptor in complex with two distinct antagonists combined with NMR, molecular docking and mutagenesis studies inform a proposed model for receptor–agonist binding.
Subfields: Animal Science and Zoology, Cellular and Molecular Neuroscience, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Molecular Biology
Citations in the corpus
- Improving homology modeling from low-sequence identity templates in Rosetta: A case study in GPCRs (2020, methodology): “The four structures were C5aR1, Y1R, PTAFR, and D2R (PDB IDs 6C1R [39], 5ZBQ [40], 5ZKQ [41], and 6CM4 [42], respectively).”
- Structural basis of neuropeptide Y signaling through Y1 receptor (2022, unknown): “7 nM) NPY(3-36) (EC50: 86 nM) NPY(18-36) (EC50: 1400 nM) NPY(AA-36) (EC50: 170 nM)”